CN103288725B - Method for synthesising milrinone - Google Patents

Method for synthesising milrinone Download PDF

Info

Publication number
CN103288725B
CN103288725B CN201310205502.3A CN201310205502A CN103288725B CN 103288725 B CN103288725 B CN 103288725B CN 201310205502 A CN201310205502 A CN 201310205502A CN 103288725 B CN103288725 B CN 103288725B
Authority
CN
China
Prior art keywords
compound
formula
milrinone
reaction
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310205502.3A
Other languages
Chinese (zh)
Other versions
CN103288725A (en
Inventor
唐咏群
段艳冰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL Co Ltd
Original Assignee
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL Co Ltd filed Critical NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL Co Ltd
Priority to CN201310205502.3A priority Critical patent/CN103288725B/en
Publication of CN103288725A publication Critical patent/CN103288725A/en
Application granted granted Critical
Publication of CN103288725B publication Critical patent/CN103288725B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

The invention discloses a method for synthesising milrinone. The method comprises the following steps of: mixing 4-methylpyridine with acetylchloride in a solvent at a temperature below 10 DEG C; heating to react with or without a catalyst, and then adjusting the pH value of the reaction solution to 7-8 by sodium hydroxide aqueous solution; then directly adding saturated sodium hydrogen sulfite aqueous solution, and reacting; adjusting the pH value of the water layer obtained by the reaction by sodium hydroxide, and reacting to obtain a compound in formula (III); mixing the compound in formula (III) with glacial acetic acid, acetic anhydride and triethyl orthoformate, and then reacting at 50-100 DEG C to obtain a compound in formula (IV); cyclizing the compound in formula (IV) with alpha-cyanoacetamide in an alkaline condition to obtain a compound in formula (V). The process is more moderate in reaction conditions, simpler and more convenient to operate, and capable of greatly shortening the original reaction time, reducing cost and increasing yield simultaneously; the process is a preparation method for milrinone which is suitable for industrialized production.

Description

The method of synthesis milrinone
Technical field
The present invention relates to improving one's methods of a kind of milrinone (1,6-dihydro-2-methyl-6-oxygen-[the two pyridine of 3,4-]-5 formonitrile HCNs) preparation technology, belong to chemical industry and chemical and medicine industry field.
Background technology
Milrinone (Milrinone) is 1,6-dihydro-2-methyl-6-oxygen-[the two pyridine of 3,4-]-5 formonitrile HCN common names, molecular formula: C 12h 9n 3o, molecular weight: 211.22, its structural formula is:
Milrinone is developed successfully by Sterling company of the U.S. the earliest, within 1987, is ratified first in the U.S. by FDA, 1992 in United States Non-Provisional listing, subsequently in Britain, France, Germany, Holland and the national list marketing such as Belgian.
This product is phosphodiesterase inhibitor, and be the homology medicine of amrinone (Amrinone), the mechanism of action is identical with amrinone.Oral and quiet note is all effective, has positive inotropic action and vasorelaxation action concurrently.But it is strong 10 ~ 30 times that it acts on comparatively amrinone.Tolerance is better.This product positive inotropic action mainly by suppressing phosphodiesterase, makes cyclic monophosphate in myocardial cell (CAMP) concentration increase, and intracellular Ca2+ increases, and myocardial contraction is strengthened, and cardiac output increases.
At present multinational in U.S. etc., intravenous injection milrinone has been widely used in the heart function improving heart failure patient.Wherein, French Sai Nuofei-Sheng Delabao company milrinone sales volume in 2000 reaches 1.8 hundred million Euros.In China, the clinical application of milrinone is also increasing, and domestic milrinone in 2011 is sold and reached nearly 6,000 ten thousand yuan, 2012, and present the trend risen year by year, be mainly used for treatment congestive heart failure, pulmonary hypertension, postcardiac surgery Low output syndromes and myocardosis.
The synthesis technique of existing many sections of documents and patent report milrinone at present, but these documents all have shortcoming in various degree, and some reaction times is longer, and some desired raw materials are expensive, and operational hazards, some aftertreatments are loaded down with trivial details or yield is lower.
Existing technique is to be divided into two class methods on the whole: first kind method is for starting raw material with 4-picoline, prepare 1-(4-pyridyl)-2-acetone, then the method priority and triethyl orthoformate, the α-Malonamide nitrile that pass through " treating different things alike " are obtained by reacting milrinone crude product, then obtain the fine work milrinone of injection stage by recrystallization.These class methods are as reaction scheme I, its the first step can be realized by 2 paths, 1st paths needs to use n-Butyl Lithium, well-known butyllithium is met water chance oxygen and easily thermopositive reaction is occurred, at air easy firing, once expanded by heating easily causes blast, therefore more difficult in operation, price is relatively expensive simultaneously, is also unfavorable for suitability for industrialized production.2nd paths and Acetyl Chloride 98Min. at room temperature react 16 hours, although reaction conditions is gentleer, the reaction times is long.With saturated sodium carbonate regulation system pH value in aftertreatment simultaneously, find to need to consume the aqueous phase being greater than 10 times amount reaction volumes, cause operational difficulty, 3 extractions, concentrating under reduced pressure is used in whole post-reaction treatment, aftertreatment is more loaded down with trivial details, and the second step reaction times is longer, adds production cost.
Equations of The Second Kind method is as route 1, same with 4-picoline for starting raw material, prepare 1-(4-pyridyl)-2-acetone, and then with propane dinitrile and triethyl orthoformate for Ethoxy methylene malononitrile 99 prepared by raw material, finally 1-(4-pyridyl)-2-acetone and Ethoxy methylene malononitrile 99 reaction are prepared milrinone crude product, obtain fine work milrinone by recrystallization equally.This method needs 3 step reactions to prepare milrinone, and can not be realized by " treating different things alike " method, therefore route is longer comparatively speaking, and final step reaction yield is lower only has 34%, relative to other routes 70% yield for can say without any competitive edge.
Summary of the invention
The object of the invention is on the basis of existing technology, a kind of new milrinone preparation technology is provided.The time that this technological reaction condition milder, operation be easier, substantially reduce original reaction simultaneously, reduce costs raising yield, be suitable for the preparation method of the milrinone of suitability for industrialized production.
Object of the present invention can be reached by following measures:
Synthesize a method for milrinone, it comprises the steps:
(1) after 4-picoline and Acetyl Chloride 98Min. mix in less than 10 DEG C in a solvent, in the presence of a catalyst in 25 DEG C ~ 30 DEG C reactions 2 ~ 4 hours, or to be warming up to 35 DEG C ~ 45 DEG C reactions 2 ~ 4 hours under catalyzer not adding, then pH value to 7 ~ 8 of reaction solution are regulated with aqueous sodium hydroxide solution, directly add saturated aqueous solution of sodium bisulfite again to react, the water layer of reaction gained regulates pH13 ~ 14 to react with sodium hydroxide again, obtains formula (III) compound;
(2), after formula (III) compound mixes with glacial acetic acid, diacetyl oxide and triethyl orthoformate, react at 50 DEG C ~ 100 DEG C, obtain formula (IV) compound;
(3) formula (IV) compound and the cyclization in the basic conditions of α-Malonamide nitrile, obtain formula V compound;
Its reaction scheme is as follows:
Solvent is in step (1) the one in methylene dichloride, sherwood oil, normal hexane, normal heptane, toluene, hexanaphthene, methyl tertiary butyl ether; The mol ratio of 4-picoline and Acetyl Chloride 98Min. is 1:1.5 ~ 2.5, is preferably 1:1.8 ~ 2.2.Catalyzer can select Lewis acid (Lewis Acid): boron trifluoride diethyl etherate, Aluminum chloride anhydrous, iron(ic) chloride, zinc chloride, cuprous bromide, fluoroform sulphonate etc., when adopting catalyzer, temperature of reaction is 25 DEG C ~ 30 DEG C, as then having a strong impact on product yield and purity higher than this scope; When not adopting catalyzer, temperature of reaction is 35 DEG C ~ 45 DEG C.
Aqueous sodium hydroxide solution concentration in step (1) has a significant impact aqueous phase amount needed for regulation system PH, and then the operation difficulty of post-reaction treatment is had a strong impact on, its suitable concentration is 0.5 ~ 6mol/L, experiment confirms, can have a strong impact on yield and the purity of formula (III) compound higher or lower than this concentration; And after adding aqueous sodium hydroxide solution adjust ph, no longer need the steps such as static layering extraction, concentrating under reduced pressure, directly can add saturated aqueous solution of sodium bisulfite to react, temperature of reaction is 20 DEG C ~ 30 DEG C, reaction times is 2 ~ 4 hours, rear point water-yielding stratum, regulates PH to 13 ~ 14 to react with aqueous sodium hydroxide solution, obtains formula (III).
In step (2), the temperature of reaction of formula (III) compound and glacial acetic acid, diacetyl oxide and triethyl orthoformate is 50 DEG C ~ 100 DEG C, and the reaction times is 0.8 ~ 3.5 hour.The mol ratio of formula (III) compound and glacial acetic acid, diacetyl oxide and triethyl orthoformate is 1:2.5 ~ 5.0:2.0 ~ 3.0:1.0 ~ 2.5.
In step (3), the solvent of ring-closure reaction is preferably anhydrous methanol, and its alkaline condition can be provided by sodium methylate, and namely ring-closure reaction carries out under the existence of sodium methylate; The temperature of ring-closure reaction is 60 DEG C ~ 70 DEG C, preferred back flow reaction.
The mol ratio of formula (IV) compound, α-Malonamide nitrile and sodium methylate in step (3) is 1:1.0 ~ 2.0:4.5 ~ 8.0.
The visible following formula of a kind of detailed reaction process of this technique:
The technique that the present invention be directed to existing milrinone syntheti c route is improved, overcoming 3 step reactions in original synthetic route has 2 step reaction required times oversize, need to use a large amount of saturated sodium carbonates in post-reaction treatment and carry out regulation system pH value, extract concentrating under reduced pressure number of times too many simultaneously, complex operation, is unfavorable for the problems such as its suitability for industrialized production.The first step reaction can be shortened to 2 ~ 4hr by this technique, and second step reaction shortens to 0.8 ~ 2hr; Aqueous phase needed for regulation system pH value reduces the aqueous phase of 1.5 ~ 3 times amount reaction volumes; The system PH of adjustment directly adds sodium bisulfite reaction, decreases extraction concentrating under reduced pressure number of times etc.Technique of the present invention saves labor cost and raw materials cost, improves efficiency, simultaneously easy operational difficulty, and does not reduce purity and the yield of target product, easily can must realize suitability for industrialized production.
Embodiment
Embodiment one:
In 100mL three-necked bottle, add 4-picoline 7.95mL (81mmol), methylene dichloride 30mL and 20mg Aluminum chloride anhydrous, ice bath is cooled to 0 DEG C and drips Acetyl Chloride 98Min. 11.7mL (165mmol), in controlling in dropping process, temperature is below 10 DEG C, 25 DEG C are warming up to, reaction 2.5hr after dropwising.In system, drip 0.5mol/L aqueous sodium hydroxide solution under ice bath cooling and regulate pH to 7 ~ 8, then add the saturated sodium sulfite solution of 19.5mL, stirring at room temperature 2.5hr.Organic layer is merged, anhydrous sodium sulfate drying with dichloromethane extraction (50mL × 2).After recycling design, 65 ~ 67 DEG C/2.7kPa cut 3.84g is collected in underpressure distillation, and this is the complete 4-picoline of unreacted.Water layer 6.25molL-1 sodium hydroxide solution adjust pH is 13.25, reacts 2hr under room temperature.Add 24mL water, with methylene dichloride (20mL × 2) extraction, anhydrous sodium sulfate drying.Underpressure distillation after recycling design, collects 100 ~ 102 DEG C/217kPa cut 3.62g, HPLC:97.73%, yield 67.38%.
1-(4-pyridyl)-2-acetone 3.0g (22.2m mol) is added in 50mL round-bottomed flask, under stirring, 5.4mL (33mmol) triethyl orthoformate, 5.7mL (60mmol) diacetyl oxide and 5.55mL (102mmol) glacial acetic acid are joined in reaction flask, 50 DEG C of stirring reactions, after TLC tracing detection 3.5hr, raw material reaction is complete.60 DEG C of concentrating under reduced pressure except desolventizing, after add dehydrated alcohol and take high boiling solvent out of, obtain dark red oil, do not need purifying to be directly used in next step reaction.Sodium methylate 15g (content >=50%, >=139mmol), α-Malonamide nitrile 2.4g (28.5m mol) and product obtained in the previous step is added, 60 DEG C of reaction 2hr in 60mL anhydrous methanol.Cold filtration, solids with methanol washes twice, then dissolves by suitable quantity of water, activated carbon decolorizing.Filtrate adjusts pH6.5 ~ 7.0 to separate out solid with Glacial acetic acid, filters and obtains milrinone crude product.Solid, with DMF-ethyl alcohol recrystallization, obtains 3.39g light yellow crystal, HPLC:99.90%, yield 72.25%.
Embodiment two:
In 1000mL three-necked bottle, add 4-picoline 63.6mL (0.648mol), normal hexane 240mL, ice bath cooling is lower drips Acetyl Chloride 98Min. 66.9mL (0.972mol), in controlling in dropping process, temperature is below 10 DEG C, 40 DEG C of back flow reaction are warming up to, reaction 3hr after dropwising.In system, 6molL is dripped under ice bath cooling -1aqueous sodium hydroxide solution regulates pH to 7 ~ 8, then adds the saturated sodium sulfite solution of 156mL, stirring at room temperature 2.5hr.Organic layer is merged, anhydrous sodium sulfate drying with n-hexane extraction (150mL × 2).After recycling design, 65 ~ 67 DEG C/2.7kPa cut 31.6g is collected in underpressure distillation, and this is the complete 4-picoline of unreacted.Water layer 6.25molL-1 sodium hydroxide solution adjust pH is 13.08, reacts 2hr under room temperature.Add 192mL water, with normal hexane (160mL × 2) extraction, anhydrous sodium sulfate drying.Underpressure distillation after recycling design, collects 100 ~ 102 DEG C/217kPa cut 28.3g, HPLC:97.97%, yield 66.82%.
1-(4-pyridyl)-2-acetone 20.0g (0.148mol) is added in 200mL round-bottomed flask, under stirring, 24.2mL (0.148mol) triethyl orthoformate, 28.1mL (0.296mol) diacetyl oxide and 20.1mL (0.37mol) glacial acetic acid are joined in reaction flask, 75 DEG C of stirring reactions, after TLC tracing detection is about 2hr, raw material reaction is complete.60 DEG C of concentrating under reduced pressure except desolventizing, after add dehydrated alcohol and take high boiling solvent out of, obtain dark red oil, do not need purifying to be directly used in next step reaction.Sodium methylate 71.9g (content >=50%, >=0.666mol), α-Malonamide nitrile 12.5g (0.148mol) and product obtained in the previous step is added, 70 DEG C of reaction 1.5hr in 400mL anhydrous methanol.Cold filtration, solids with methanol washes twice, then dissolves by suitable quantity of water, activated carbon decolorizing.Filtrate adjusts pH6.5 ~ 7.0 to separate out solid with Glacial acetic acid, filters and obtains milrinone crude product.Solid, with DMF-ethyl alcohol recrystallization, obtains 22.0g light yellow crystal, HPLC:99.90%, yield 70.4%.
Embodiment three:
In 2000mL three-necked bottle, add 4-picoline 200mL (2.038mol), hexanaphthene 800mL and 1mL copper trifluoromethanesulfcomposite, ice bath cooling is lower drips Acetyl Chloride 98Min. 361.3mL (5.092mol), in controlling in dropping process, temperature is below 10 DEG C, is warming up to 30 DEG C of reaction 3.5hr after dropwising.In system, drip 4molL-1 aqueous sodium hydroxide solution under ice bath cooling and regulate pH to 7 ~ 8, then add the saturated sodium sulfite solution of 491mL, stirring at room temperature 2.5hr.Organic layer is merged, anhydrous sodium sulfate drying with hexanaphthene extraction (400mL × 2).After recycling design, 65 ~ 67 DEG C/2.7kPa cut 93.95g is collected in underpressure distillation, and this is the complete 4-picoline of unreacted.Water layer 6.25m olL-1 sodium hydroxide solution adjust pH is 13.18, reacts 2hr under room temperature.Add 600mL water, with hexanaphthene (500mL × 2) extraction, anhydrous sodium sulfate drying.Underpressure distillation after recycling design, collects 100 ~ 102 DEG C/217kPa cut 100.3g, HPLC:94.51%, yield 71.15%.
1-(4-pyridyl)-2-acetone 50.0g (0.37mol) is added in 500mL round-bottomed flask, under stirring, 151.4mL (0.925mol) triethyl orthoformate, 105.5mL (1.11mol) diacetyl oxide and 100.7mL (1.85mol) glacial acetic acid are joined in reaction flask, 100 DEG C of stirring reactions, after TLC tracing detection 0.8hr, raw material reaction is complete.60 DEG C of concentrating under reduced pressure except desolventizing, after add dehydrated alcohol and take high boiling solvent out of, obtain dark red oil, do not need purifying to be directly used in next step reaction.Sodium methylate 320g (content >=50%, >=2.96mol), α-Malonamide nitrile 62.3g (0.74mol) and product obtained in the previous step is added, back flow reaction 1.5hr in 1000mL anhydrous methanol.Cold filtration, solids with methanol washes twice, then dissolves by suitable quantity of water, activated carbon decolorizing.Filtrate adjusts pH6.5 ~ 7.0 to separate out solid with Glacial acetic acid, filters and obtains milrinone crude product.Solid, with DMF-ethyl alcohol recrystallization, obtains 58.3g light yellow crystal, HPLC:99.93%, yield 74.6%.
Comparative example:
In 1000mL three-necked bottle, add 4-picoline 63.6mL (0.648mol), methylene dichloride 240mL, ice bath cooling is lower drips Acetyl Chloride 98Min. 93.6mL (1.32mol), in controlling in dropping process, temperature is below 10 DEG C, 40 DEG C of back flow reaction are warming up to, reaction 3hr after dropwising.In system, drip 8molL-1 aqueous sodium hydroxide solution under ice bath cooling and regulate pH to 7 ~ 8, then add the saturated sodium sulfite solution of 156mL, stirring at room temperature 2.5hr.Organic layer is merged, anhydrous sodium sulfate drying with dichloromethane extraction (150mL × 2).After recycling design, 65 ~ 67 DEG C/2.7kPa cut 31.6g is collected in underpressure distillation, and this is the complete 4-picoline of unreacted.Water layer 6.25molL-1 sodium hydroxide solution adjust pH is 13.20, reacts 2hr under room temperature.Add 192mL water, with methylene dichloride (160mL × 2) extraction, anhydrous sodium sulfate drying.Underpressure distillation after recycling design, collects 100 ~ 102 DEG C/217kPa cut 22.5g, HPLC:89.24%, yield 53.13%.Regulate pH to 7 ~ 8 and embodiment two to contrast with concentration 8molL-1 aqueous sodium hydroxide solution, formula (III) compound yield reduces to 53.13% from original 66.82%, and HPLC purity also reduced nearly 10%, and product purity is lower, and color becomes tawny from faint yellow.

Claims (7)

1. synthesize a method for milrinone, it is characterized in that comprising the steps:
(1) after 4-picoline and Acetyl Chloride 98Min. mix in less than 10 DEG C in a solvent, in 25 DEG C ~ 30 DEG C reactions 2 ~ 4 hours under catalyzer copper trifluoromethanesulfcomposite exists, then pH value to 7 ~ 8 of reaction solution are regulated with 0.5 ~ 6mol/L aqueous sodium hydroxide solution, directly add saturated aqueous solution of sodium bisulfite again to react 2 ~ 4 hours at 20 DEG C ~ 30 DEG C, then water-yielding stratum is divided, pH to 13 ~ 14 are regulated again with 0.5 ~ 6mol/L sodium hydroxide, react 2 ~ 3 hours, obtain formula (III) compound;
(2), after formula (III) compound mixes with glacial acetic acid, diacetyl oxide and triethyl orthoformate, react at 50 DEG C ~ 100 DEG C, obtain formula (IV) compound;
(3) formula (IV) compound and the cyclization in the basic conditions of α-Malonamide nitrile, obtain formula (V) compound;
Its reaction scheme is as follows:
2. the method for synthesis milrinone according to claim 1, is characterized in that the solvent in step (1) is methylene dichloride, sherwood oil, normal hexane, normal heptane, toluene, hexanaphthene or methyl tertiary butyl ether; The mol ratio of 4-picoline and Acetyl Chloride 98Min. is 1:1.5 ~ 2.5.
3. the method for synthesis milrinone according to claim 1, the temperature of reaction that it is characterized in that formula (III) compound in step (2) and glacial acetic acid, diacetyl oxide and triethyl orthoformate is 50 DEG C ~ 100 DEG C, and the reaction times is 0.8 ~ 3.5 hour.
4. the method for synthesis milrinone according to claim 1, is characterized in that the mol ratio of formula (III) compound in step (2) and glacial acetic acid, diacetyl oxide and triethyl orthoformate is 1:2.5 ~ 5.0:2.0 ~ 3.0:1.0 ~ 2.5.
5. the method for synthesis milrinone according to claim 1, is characterized in that in step (3), and the solvent of ring-closure reaction is anhydrous methanol, and ring-closure reaction carries out under the existence of sodium methylate.
6. the method for synthesis milrinone according to claim 1, is characterized in that in step (3), and the temperature of ring-closure reaction is 60 DEG C ~ 70 DEG C.
7. the method for synthesis milrinone according to claim 5, is characterized in that the mol ratio of formula (IV) compound, α-Malonamide nitrile and the sodium methylate in step (3) is 1:1.0 ~ 2.0:4.5 ~ 8.0.
CN201310205502.3A 2013-05-27 2013-05-27 Method for synthesising milrinone Active CN103288725B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310205502.3A CN103288725B (en) 2013-05-27 2013-05-27 Method for synthesising milrinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310205502.3A CN103288725B (en) 2013-05-27 2013-05-27 Method for synthesising milrinone

Publications (2)

Publication Number Publication Date
CN103288725A CN103288725A (en) 2013-09-11
CN103288725B true CN103288725B (en) 2015-04-08

Family

ID=49090318

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310205502.3A Active CN103288725B (en) 2013-05-27 2013-05-27 Method for synthesising milrinone

Country Status (1)

Country Link
CN (1) CN103288725B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965101B (en) * 2014-05-21 2016-07-06 合肥久诺医药科技有限公司 A kind of preparation method of milrinone
CN104387320B (en) * 2014-09-28 2018-01-26 湖州展望药业股份有限公司 A kind of preparation method of high-purity milrinone
CN104326975A (en) * 2014-10-20 2015-02-04 郑州四环医药用品有限公司 Preparation method of high-purity milrinone
CN105777626A (en) * 2014-12-18 2016-07-20 扬子江药业集团上海海尼药业有限公司 Preparation method of milrinone
CN104744357A (en) * 2015-03-30 2015-07-01 浙江中维药业有限公司 Recrystallization purification method of milrinone
CN105037261B (en) * 2015-07-03 2017-11-24 湖南赛隆药业有限公司 A kind of method for synthesizing milrinone
CN106243032A (en) * 2016-07-20 2016-12-21 扬子江药业集团江苏海慈生物药业有限公司 A kind of preparation method of milrinone
CN106632025A (en) * 2016-11-30 2017-05-10 湖州恒远生物化学技术有限公司 Method for preparing milrinone
CN108440395A (en) * 2018-04-04 2018-08-24 梯尔希(南京)药物研发有限公司 A kind of preparation method of milrinone impurity
CN111484450A (en) * 2019-01-28 2020-08-04 上海隆盛化工有限公司 Preparation method of medical intermediate milrinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1026584C (en) * 1987-04-03 1994-11-16 重庆医药工业研究所 Preparation for pyridine methyl alkyl (aromatic) ketones

Also Published As

Publication number Publication date
CN103288725A (en) 2013-09-11

Similar Documents

Publication Publication Date Title
CN103288725B (en) Method for synthesising milrinone
CN104130258B (en) The method for transformation of a kind of dimer
CN103724329A (en) Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
CN106365986B (en) Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
CN105418483A (en) Preparation method of crystalline nintedanib esylate
CN107245045A (en) A kind of preparation method for the ground ostelin that ends
CN106243032A (en) A kind of preparation method of milrinone
CN108218798B (en) Preparation method of Apabetalone
CN105837493A (en) A synthetic method of Nintedanib and an intermediate of Nintedanib
CN109438423A (en) A kind of new method of the synthesis technology of lung cancer target compound AZD-3759
CN115819408B (en) Method for synthesizing rosuvastatin key intermediate with high selectivity
CN113336764B (en) Bipyridine ligand with axial chirality and synthetic method thereof
CN104478984B (en) The preparation method and application of amphipathic Tb (III) complex and preparation method thereof and helical form fluorescent nano-fiber
WO2014180271A1 (en) Method for preparing afatinib and intermediate thereof
CN113004233A (en) Compound for preparing PRC2 inhibitor, preparation method and application thereof
CN104230818B (en) The improvement preparation method of ticagrelor midbody
CN103641879B (en) The preparation method of prednisolone intermediate or its analogue
CN103073525B (en) Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide
CN102030761B (en) Prasugrel midbody and preparation method thereof
CN103641876B (en) The preparation method of cortisone acetic ester
CN113121354A (en) Synthesis method of substituted biphenyl compound
CN104774183B (en) A kind of auspicious relax of formoxyl cuts down the preparation method of spit of fland calcium intermediate
CN103254156A (en) Preparation method of afatinib intermediate
CN102432558B (en) Method for synthesizing irbesartan and intermediate thereof
CN103804201A (en) Synthesis method for intermediate 3-aminophenylacetylene of antitumor drug erlotinib

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant